Viread (VEER-ee-ad), the ONCE-DAILY antiretroviral drug

You can now get Viread (VEER-ee-ad), the ONCE-DAILY antiretroviral drug...from Gilead Sciences.

Viread (tenofovir) is the first nucleoTIDE reverse transcriptase inhibitor. It's similar in structure to the nucleoSIDE reverse transcriptase inhibitors...but might be more active.

Viread also appears to have fewer drug interactions, cause fewer side effects, and might be less likely to develop resistance.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote